The Competition Commission of India (CCI) has granted approval for the acquisition of 100% of the equity share capital of Sahrudaya Health Care Private Limited by Maybach Asia Holdings II Pte. Ltd. This proposed combination involves the complete takeover of the target company by the acquirer entity.
Maybach Asia Holdings II Pte. Ltd. is a special purpose vehicle incorporated specifically for this transaction and is indirectly owned by investment funds, vehicles, and/or accounts advised and managed by various subsidiaries of global investment firm KKR & Co. Inc.
Sahrudaya Health Care Private Limited, through its subsidiaries, operates a multi-specialty hospital network comprising 28 hospitals/units with approximately 4800 beds across south and west India. The healthcare provider offers comprehensive care across more than 80 clinical specialties, including cardiology, neurology, gastroenterology, nephrology, oncology, orthopedics, critical care, women's health, and other medical and surgical specialties.
The approval was officially posted on October 22, 2026, through the Press Information Bureau Delhi, with release ID 2326892.